2022 American Transplant Congress » Liver: Immunosuppression and Rejection

Date: Sunday, June 5, 2022

Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

Session Type: Poster Abstract

Meeting: 2022 American Transplant Congress

7:00pm-8:00pm: An Interim Report on a Prospective Randomized Trial of Extended-Release Tacrolimus in Liver Transplantation with Anti-Thymocyte Induction in a Steroid Free Protocol

R. A. Helmick, S. Naik, C. Eymard, J. Eason, J. Vanatta

7:00pm-8:00pm: Impact of Induction Immunosuppression on Renal Recovery in Adult Liver Transplant Recipients – A Single Center Experience

T. Zurick¹, D. Bruno², D. Kumar³, R. Winstead¹, C. Song¹, A. Brown¹, S. Sterling¹, I. Yakubu¹

7:00pm-8:00pm: Induction Immunosuppression in ABO-Incompatible Liver Transplant Recipients

S. Shaikh¹, I. Hasan¹, N. Kaur²

7:00pm-8:00pm: Is a Single Dose of Steroids in Adult Living Donor Liver Transplant Safe? – A Cohort Analysis

M. Nunez, C. Praglin, A. M. Torres, E. Agudelo, H. Braun, C. Huang, S. Syed, J. Roberts, G. Roll

7:00pm-8:00pm: Recipient and Center Factors Associated with Immunosuppression Practice Beyond the First Year After Liver Transplantation

T. Bittermann¹, D. Goldberg²

« View all sessions from the 2022 American Transplant Congress